Information for Patients

Many cellular immunotherapy patients have questions about how to move forward and stay healthy when their immunotherapy treatment is complete. We’ve created resources that address the most common questions we receive.

If you have questions after getting cellular immunotherapy at Fred Hutch Cancer Center, you can call the Cellular Immunotherapy Long-Term Follow-Up (LTFU) Program at 206.667.5811 and email us at imtxltfu@fredhutch.org.

Frequently Asked Questions

Find resources on cancer, treatment and survivorship

Latest Cellular Immunotherapy LTFU News

All news
RNA “typos” can highlight leukemia cells for immune attack Looking beyond DNA, scientists find possible “surgically targeted” option for splicing factor-mutant blood cancers that lack effective immunotherapies April 23, 2025
Surprising findings about blood cell mutations bode well for transplant recipients Fred Hutch researchers compared blood samples from 16 recipient-donor pairs, some more than 45 years after transplant January 10, 2025
Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology In-house grant funding program will underpin efforts to advance therapies to clinical trials August 15, 2024
Endocrine Tumor Program at Fred Hutch launches survivorship clinic New clinic provides long-term care for thyroid tumors and endocrine immune-related adverse events August 24, 2023
Fred Hutch campus

Contact Cellular Immunotherapy LTFU

Hours: Monday–Friday, 8 a.m.–4 p.m.

Mailing Address:
Fred Hutch Cancer Center
ATTN: IMTX LTFU
1100 Fairview Ave. N
Mail Stop M2-A876
Seattle, WA 98109

Phone:

206.667.5811

Fax:

978.528.1245